Novo Integrated Sciences, Inc.
NVOS · OTC
8/31/2024 | 8/31/2023 | 8/31/2022 | 8/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1 | $0 | $2 | $8 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $3 | $1 | $1 | $2 |
| Inventory | $1 | $1 | $1 | $0 |
| Other Curr. Assets | $0 | $1 | $2 | $0 |
| Total Curr. Assets | $5 | $4 | $6 | $11 |
| Property Plant & Equip (Net) | $7 | $7 | $8 | $9 |
| Goodwill | $7 | $8 | $8 | $9 |
| Intangibles | $13 | $16 | $19 | $32 |
| Long-Term Investments | $0 | $0 | $0 | $1 |
| Tax Assets | $0 | $0 | $0 | -$1 |
| Other NC Assets | $0 | $0 | $0 | $1 |
| Total NC Assets | $27 | $31 | $35 | $51 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $32 | $36 | $41 | $62 |
| Liabilities | – | – | – | – |
| Payables | $3 | $4 | $2 | $1 |
| Short-Term Debt | $3 | $3 | $10 | $6 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $8 | $2 | $3 | $1 |
| Total Curr. Liab. | $15 | $8 | $14 | $8 |
| LT Debt | $3 | $2 | $3 | $8 |
| Deferred Rev, NC | $0 | -$1 | -$1 | -$2 |
| Deferred Tax Liab, NC | $1 | $1 | $1 | $2 |
| Other NC Liab. | $0 | $1 | $1 | $2 |
| Total NC Liab. | $3 | $3 | $5 | $10 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $2 | $3 | $3 |
| Total Liabilities | $18 | $11 | $19 | $18 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$83 | -$67 | -$54 | -$21 |
| AOCI | $1 | -$0 | $10 | $10 |
| Other Equity | $97 | $92 | $66 | $55 |
| Total Equity | $15 | $25 | $22 | $44 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$0 | -$0 | -$0 | -$0 |
| Total Liab. & Tot. Equity | $32 | $36 | $41 | $62 |
| Net Debt | $5 | $4 | $11 | $5 |